Gregg L Semenza

19PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer cell biologyNeural engineeringHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 06, 2026
Targeting conserved domains of hypoxia-inducible factors for cancer therapy.

Shaima Salman, Tina Y Huang, Yousang Hwang

|Dec 12, 2025
HIF-1-mediated ISG20 expression promotes breast cancer stemness and immune evasion.

Yongkang Yang, Qiaozhu Zuo, Vijay Ramu

|Nov 05, 2024
VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept.

Deepti Sharma, Evan Lau, Yu Qin

|Oct 14, 2024
Master Role of Hypoxia in Cancer Progression: Major Insights During ISOTT's Half-Century.

Peter Vaupel, Gregg L Semenza

|Aug 28, 2024
Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy.

Walter Jackson Iii, Yongkang Yang, Shaima Salman

|Sep 28, 2023
Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.

Gregg L Semenza

Pageof 4

Frequent Collaborators

6 joint publications

Yajing Lyu

5 joint publications

Shaima Salman

4 joint publications

Chelsey Chen

4 joint publications

Yongkang Yang